Naresh Bumma: Clinical Trials

1 trial sponsored by Naresh Bumma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Naresh Bumma: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma
Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography - Cytokine Release Syndrome, Recurrent Multiple Myeloma
Phase 2RecruitingNaresh Bumma352026-07-172026-10-06

Conditions studied

Cytokine Release Syndrome (1)  ·  Multiple Myeloma (1)

Interventions

Biopsy (1)  ·  CT-P13 (1)  ·  Infliximab (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Phantoms, Imaging (1)  ·  Specimen Handling (1)  ·  X-Rays (1)  ·  talquetamab (1)

Countries

United States (1)